文献速递糖尿病

循环小非编码RNA谱作为1型糖尿病动脉粥样硬化斑块成分的潜在生物标志物

Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2023-01-01

研究对1型糖尿病患者颈动脉钙化斑块(CCP)与纤维斑块(CFP)的循环小非编码RNA进行测序和验证,发现miR-503-5p、let-7d-5p、miR-106b-3p、miR-93-5p在CCP中显著上调,miR-10a-5p下调,且与LDL-胆固醇相关,提示其可能作为斑块成分的生物标志物。

要点

  • 在1型糖尿病中,CCP患者循环miR-503-5p、let-7d-5p、miR-106b-3p和miR-93-5p较CFP显著上调,miR-10a-5p下调。
  • CCP中所有候选miRNA与LDL-胆固醇显著相关,上调者呈正相关,下调者呈负相关。
  • 上调miRNA的靶基因参与成骨分化、凋亡、炎症、胆固醇代谢和细胞外基质组织。

核心结论

  • 这些发现刻画了1型糖尿病中颈动脉斑块表型调控网络相关的miRNA及其特征,为斑块病理生理学提供了新见解,并可能成为斑块成分的新型生物标志物。

研究设计与样本

  • 探索集纳入26例伴CCP的1型糖尿病患者和25例伴CFP的1型糖尿病患者,采用下一代测序和生物信息学分析对循环小非编码RNA进行测序和定量。
  • 验证集纳入40例伴CCP、40例伴CFP和24例伴1型糖尿病的对照受试者,采用数字液滴PCR测定所选miRNA的表达。
  • 分析了富集于动脉粥样硬化、血管钙化和糖尿病相关通路的推定靶基因,并记录了患者的主要临床特征。

主要发现

  • 与CFP患者相比,CCP患者的miR-503-5p、let-7d-5p、miR-106b-3p和miR-93-5p显著上调,而miR-10a-5p下调(所有倍数变化>±1.5;P<0.05)。
  • 在CCP中,所有候选miRNA均与LDL-胆固醇显著相关,上调的miRNA呈直接相关,下调的miRNA呈负相关。
  • CCP中上调miRNA的许多靶基因参与成骨分化、凋亡、炎症、胆固醇代谢和细胞外基质组织。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cardiovascular disease (CVD) accounts for most deaths in patients with type 1 diabetes (T1D); however, the determinants of plaque composition are unknown. miRNAs regulate gene expression, participate in the development of atherosclerosis, and represent promising CVD biomarkers. This study analyzed the circulating miRNA expression profile in T1D with either carotid calcified (CCP) or fibrous plaque (CFP). RESEARCH DESIGN AND METHODS: Circulating small noncoding RNAs were sequenced and quantified using next-generation sequencing and bioinformatic analysis in an exploratory set of 26 subjects with T1D with CCP and in 25 with CFP. Then, in a validation set of 40 subjects with CCP, 40 with CFP, and 24 control subjects with T1D, selected miRNA expression was measured by digital droplet PCR. Putative gene targets enriched for pathways implicated in atherosclerosis/vascular calcification/diabetes were analyzed. The patients' main clinical characteristics were also recorded. RESULTS: miR-503-5p, let-7d-5p, miR-106b-3p, and miR-93-5p were significantly upregulated, while miR-10a-5p was downregulated in patients with CCP compared with CFP (all fold change >±1.5; P < 0.05). All candidate miRNAs showed a significant correlation with LDL-cholesterol, direct for the upregulated and inverse for the downregulated miRNA, in CCP. Many target genes of upregulated miRNAs in CCP participate in osteogenic differentiation, apoptosis, inflammation, cholesterol metabolism, and extracellular matrix organization. CONCLUSIONS: These findings characterize miRNAs and their signature in the regulatory network of carotid plaque phenotype in T1D, providing new insights into plaque pathophysiology and possibly novel biomarkers of plaque composition.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Giannella A, Castelblanco E, Zambon CF, et al. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes Care. 2023. PMID: 36577032. doi:10.2337/dc22-1441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。